← The library
Investigational

Klotho

aka α-Klotho protein

A protein your kidneys make. People with more of it tend to live longer.

Technically · Anti-aging hormone / protein

longevitysleeplibido
Klotho
The vial
K
The molecule

In one sentence

A protein your kidneys make that strongly tracks with how long you'll live. New recombinant version dosed every 2 weeks.

Like a longevity biomarker you can actually inject. Strong correlations, early human data, expensive.

Half-life

~19 days (albumin-bound)

The lab-made version lasts ~19 days. One shot every two weeks.

Dosing

Every 2 weeks SubQ

How often you take a dose

Route

SubQ

How it goes into the body

Status

Investigational

Still in clinical trials, not on the market

Education only. Many compounds discussed are research chemicals not approved for human use in the US. This is not medical advice — consult a licensed physician.

What it is

Klotho is a protein your kidneys produce naturally. Researchers noticed years ago that people with higher levels live longer healthier lives, with better heart, brain, and kidney function. A recombinant (lab-made) version is now available through compounding pharmacies. Long half-life means one shot every two weeks.

The full technical answer

A protein produced primarily by the kidneys. Higher Klotho levels correlate strongly with longer healthspan in observational studies. Recombinant Klotho is now available via compounding pharmacies — Jay Campbell's 2026 standout longevity peptide.

How it works

Klotho touches several systems at once: it regulates calcium and phosphate, helps your blood vessels stay flexible, modulates aging-related growth signals, and even crosses into the brain. Animal studies show neuroprotection. Early human data is encouraging but not conclusive.

The full technical answer

Modulates FGF23 signaling, calcium-phosphate balance, insulin sensitivity, and TGF-β pathways. Endothelial protective. Crosses blood-brain barrier and shows neuroprotective effects in animal models.

ExtracellularInside the cellFGF23ReceptorTGF-βReceptorpeptidedownstream signaling
Receptors hit: FGF23, TGF-β. The peptide binds the receptor on the cell surface, triggering downstream signaling inside the cell.

What the research says

Strong observational data linking serum Klotho to longevity. Limited human RCT data on supplementation. Jay Campbell reports significant subjective improvement after 4 months — endothelial function, sleep, libido, mood. Albumin-bound version has 19-day half-life.

Sources: PubMed: Klotho longevity

Common dosing ranges

Range
10 mcg per dose (albumin-bound)
Frequency
Every 2 weeks SubQ
Duration
Ongoing — long half-life means infrequent dosing

Sources: PubMed

How to take it

Practical guidance synthesized from clinical protocols, FDA labels, and clinician interviews. Always cross-check with a prescribing physician.

Best time of day

Every 14 days, any time of day, any day of the week. Long half-life means a missed dose isn't catastrophic.

With food or fasted

Doesn't matter — SubQ injection.

How long to cycle

Ongoing. No established cycling protocol — most early users run it continuously.

When to get off

Cost barrier (~$380/month) is the most common stop reason. Any injection-site reaction or unusual symptoms → consult physician.

Administration

SubQ

Side effects

Common

  • Generally well-tolerated in early reports

Serious / theoretical

  • Long-term human safety data not yet established
  • Cost barrier (~$380/month) — verify source quality

Sources: PubMed

Notes

Jay Campbell calls it "the fountain of youth molecule" in 2026 podcasts. Tyna Moore notes secondary benefits for menstrual cycle regulation in some users (anecdotal).

Further reading & listening

Where the experts go deeper.

Curated from the PeptideFacts expert directory — vetted YouTube channels, podcasts, books, and communities. No anecdote-only or supplier-affiliated picks.

Often compared